Status:
COMPLETED
Non-Nicotine Agents for Smoking Cessation
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therap...
Detailed Description
This study is a two-arm open-label, randomized controlled trial of bupropion combined with transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with all subjects recei...
Eligibility Criteria
Inclusion
- Readiness to set a quit date in the next two weeks,
- Current smoking of at least 15 cigarettes a day
Exclusion
- Current untreated depression or receiving treatment for depression,
- History of seizures, major head injury, or other predisposition for seizures
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00108537
Start Date
October 1 2003
End Date
September 1 2005
Last Update
April 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver VA Medical Center
Denver, Colorado, United States, 80220